monoclonal antibody M-T412
199/12050
Phase 1 small_molecule completed
Quick answer
monoclonal antibody M-T412 for Multiple Sclerosis is a Phase 1 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Multiple Sclerosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed